- Category : Healthcare
- Region : APAC
- Publishing Date : 06/30/2022
Asia Pacific Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity
Asia Pacific ophthalmic drug delivery system market will grow by 8.9% annually with a total addressable market cap of $56,139.1 million over 2022-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.
Highlighted with 27 tables and 56 figures, this 127-page report “Asia Pacific Ophthalmic Drug Delivery System Market 2021-2031 by Product (Syringes, Eyedroppers, Dispensers, Sprayers, Contact Lenses, Inserts, Implants, Plugs), Dosage Form (Solutions, Gels, Ointments, Suspensions, Emulsions, Liposomes & Nanoparticles), Disease (Glaucoma, Diabetic Retinopathy, Cataract, Dry Eye Syndrome, Macular Degeneration, Diabetic Macular Edema, Refractive Issues), Setting (Hospitals, Clinics, Homecare Settings, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pre-filled Syringes
• Multidose Eyedroppers
• Squeeze Dispensers
• Mist Sprayers
• Contact Lenses
• Ocular Inserts
• Intraocular Implants
• Punctal Plugs
• Other Products
Based on Dosage Form, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Solutions
• Gels
• Ointments
• Suspensions
• Emulsions
• Liposomes & Nanoparticles
By Disease, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Glaucoma
• Diabetic Retinopathy
• Cataract
• Dry Eye Syndrome
• Macular Degeneration
• Diabetic Macular Edema
• Refractive Issues
• Other Diseases
By Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)
• Other Settings
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Dosage Form, and Setting over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aero Pump GmbH
Allergan plc.
AptarGroup, Inc.
Becton, Dickinson and Company
Biocorp
Clearside Biomedical, Inc.
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer AG
Jotteq Inc.
Kedalion Therapeutics, Inc.
Mati Therapeutics, Inc.
Nemera
Nipro Corporation
Ocular Therapeutix, Inc.
Ocumedic, Inc.
Owen Mumford
Re-Vana Therapeutics
Silgan Holdings Inc.
Terumo Corporation
Valeant Pharmaceuticals International Inc. (Bausch Health Company)
West Pharmaceutical Services, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
List of Tables:
Table 1. Snapshot of Asia Pacific Ophthalmic Drug Delivery System Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 22
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Ophthalmic Drug Delivery System Market 32
Table 4. Asia Pacific Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 40
Table 5. Asia Pacific Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 51
Table 6. Asia Pacific Ophthalmic Drug Delivery System Market by Disease, 2021-2031, $ mn 59
Table 7. Asia Pacific Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 69
Table 8. APAC Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 77
Table 9. Japan Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 81
Table 10. Japan Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 81
Table 11. Japan Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 82
Table 12. China Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 84
Table 13. China Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 84
Table 14. China Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 85
Table 15. Australia Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 87
Table 16. Australia Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 87
Table 17. Australia Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 88
Table 18. India Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 90
Table 19. India Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 90
Table 20. India Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 91
Table 21. South Korea Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 93
Table 22. South Korea Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 93
Table 23. South Korea Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 94
Table 24. Ophthalmic Drug Delivery System Market in Rest of APAC by Country/Region, 2021-2031, $ mn 96
Table 25. Aero Pump GmbH: Company Snapshot 101
Table 26. Aero Pump GmbH: Business Segmentation 102
Table 27. Aero Pump GmbH: Product Portfolio 102
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of Asia Pacific Market by Product 40
3.1 Market Overview by Product 40
3.2 Pre-filled Syringes 42
3.3 Multidose Eyedroppers 43
3.4 Squeeze Dispensers 44
3.5 Mist Sprayers 45
3.6 Contact Lenses 46
3.7 Ocular Inserts 47
3.8 Intraocular Implants 48
3.9 Punctal Plugs 49
3.10 Other Products 50
4 Segmentation of Asia Pacific Market by Dosage Form 51
4.1 Market Overview by Dosage Form 51
4.2 Solutions 53
4.3 Gels 54
4.4 Ointments 55
4.5 Suspensions 56
4.6 Emulsions 57
4.7 Liposomes & Nanoparticles 58
5 Segmentation of Asia Pacific Market by Disease 59
5.1 Market Overview by Disease 59
5.2 Glaucoma 61
5.3 Diabetic Retinopathy 62
5.4 Cataract 63
5.5 Dry Eye Syndrome 64
5.6 Macular Degeneration 65
5.7 Diabetic Macular Edema 66
5.8 Refractive Issues 67
5.9 Other Diseases 68
6 Segmentation of Asia Pacific Market by Setting 69
6.1 Market Overview by Setting 69
6.2 Hospitals 71
6.3 Clinics 72
6.4 Homecare Settings 73
6.5 Ambulatory Surgical Centers (ASCs) 74
6.6 Other Settings 75
7 Asia-Pacific Market 2021-2031 by Country 76
7.1 Overview of Asia-Pacific Market 76
7.2 Japan 79
7.3 China 83
7.4 Australia 86
7.5 India 89
7.6 South Korea 92
7.7 Rest of APAC Region 95
8 Competitive Landscape 97
8.1 Overview of Key Vendors 97
8.2 New Product Launch, Partnership, Investment, and M&A 100
8.3 Company Profiles 101
Aero Pump GmbH 101
Allergan plc. 103
AptarGroup, Inc. 104
Becton, Dickinson and Company 105
Biocorp 106
Clearside Biomedical, Inc. 107
EyePoint Pharmaceuticals, Inc. 108
Gaplast GmbH 109
Gerresheimer AG 110
Jotteq Inc. 111
Kedalion Therapeutics, Inc. 112
Mati Therapeutics, Inc. 113
Nemera 114
Nipro Corporation 115
Ocular Therapeutix, Inc. 116
Ocumedic, Inc. 117
Owen Mumford 118
Re-Vana Therapeutics 119
Silgan Holdings Inc. 120
Terumo Corporation 121
Valeant Pharmaceuticals International Inc. (Bausch Health Company) 122
West Pharmaceutical Services, Inc. 123
RELATED REPORTS 124